Rook AH - Search Results

1

Role of (18)F-fluorodeoxyglucose positron emission tomography imaging in the management of primary cutaneous lymphomas.

Spaccarelli N, Gharavi M, Saboury B, Cheng G, Rook AH, Alavi A. Spaccarelli N, et al. Among authors: rook ah. Hell J Nucl Med. 2014 May-Aug;17(2):78-84. doi: 10.1967/s002449910131. Epub 2014 Jul 5. Hell J Nucl Med. 2014. PMID: 24997076 Review.

2

Assessment of tumor burden and treatment response by 18F-fluorodeoxyglucose injection and positron emission tomography in patients with cutaneous T- and B-cell lymphomas.

Shapiro M, Yun M, Junkins-Hopkins JM, Vittorio CC, Schulman N, Saidman BH, Fried RG, Rook AH, Alavi A. Shapiro M, et al. Among authors: rook ah. J Am Acad Dermatol. 2002 Oct;47(4):623-8. doi: 10.1067/mjd.2002.124076. J Am Acad Dermatol. 2002. PMID: 12271315

3

Global Quantitative Techniques for Positron Emission Tomographic Assessment of Disease Activity in Cutaneous T-Cell Lymphoma and Response to Treatment.

Fardin S, Gholami S, Samimi S, Rook AH, Alavi A. Fardin S, et al. Among authors: rook ah. JAMA Dermatol. 2016 Jan;152(1):103-5. doi: 10.1001/jamadermatol.2015.2706. JAMA Dermatol. 2016. PMID: 26422531 No abstract available.

4

The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma.

Spaccarelli N, Rook AH. Spaccarelli N, et al. Among authors: rook ah. Dermatol Clin. 2015 Oct;33(4):731-45. doi: 10.1016/j.det.2015.05.008. Epub 2015 Aug 20. Dermatol Clin. 2015. PMID: 26433845 Free article. Review.

5

Management of relapsed cutaneous T-Cell lymphoma following allogeneic hematopoietic stem cell transplantation: Review with representative patient case.

Weiner DM, Lewis DJ, Spaccarelli NG, Clark RA, Nasta SD, Loren AW, Rook AH, Kim EJ. Weiner DM, et al. Among authors: rook ah. Dermatol Ther. 2022 Jul;35(7):e15538. doi: 10.1111/dth.15538. Epub 2022 May 9. Dermatol Ther. 2022. PMID: 35477952 Review.

6

Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas.

Paralkar VR, Nasta SD, Morrissey K, Smith J, Vassilev P, Martin ME, Goldstein SC, Loren A, Rook AH, Kim EJ, Porter DL. Paralkar VR, et al. Among authors: rook ah. Bone Marrow Transplant. 2012 Jul;47(7):940-5. doi: 10.1038/bmt.2011.201. Epub 2011 Oct 24. Bone Marrow Transplant. 2012. PMID: 22020023 Free PMC article.

7

Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.

Gormley RH, Hess SD, Anand D, Junkins-Hopkins J, Rook AH, Kim EJ. Gormley RH, et al. Among authors: rook ah. J Am Acad Dermatol. 2010 Feb;62(2):300-7. doi: 10.1016/j.jaad.2009.02.035. Epub 2009 Nov 26. J Am Acad Dermatol. 2010. PMID: 19944484 Review.

8

Update on treatment of cutaneous T-cell lymphoma.

Gardner JM, Evans KG, Musiek A, Rook AH, Kim EJ. Gardner JM, et al. Among authors: rook ah. Curr Opin Oncol. 2009 Mar;21(2):131-7. doi: 10.1097/CCO.0b013e3283253190. Curr Opin Oncol. 2009. PMID: 19532014 Review.

9

The role for interleukin-12 therapy of cutaneous T cell lymphoma.

Rook AH, Zaki MH, Wysocka M, Wood GS, Duvic M, Showe LC, Foss F, Shapiro M, Kuzel TM, Olsen EA, Vonderheid EC, Laliberte R, Sherman ML. Rook AH, et al. Ann N Y Acad Sci. 2001 Sep;941:177-84. doi: 10.1111/j.1749-6632.2001.tb03721.x. Ann N Y Acad Sci. 2001. PMID: 11594571 Clinical Trial.

10

New biologic agents for the treatment of cutaneous T-cell lymphoma.

Vittorio CC, Junkins-Hopkins JM, McGinnis KS, Shapiro M, Wysocka M, Zaki MH, French LE, Rook AH. Vittorio CC, et al. Among authors: rook ah. Recent Results Cancer Res. 2002;160:321-8. doi: 10.1007/978-3-642-59410-6_37. Recent Results Cancer Res. 2002. PMID: 12079230 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters